User profiles for Markus Bitzer

Markus Bitzer

Verified email at med.umich.edu
Cited by 8012

TGF-ß signaling in renal disease

EP Bo, M Bitzer - Journal of the American society of nephrology, 2002 - journals.lww.com
… We also found Smad3-dependent regulation of DAPK in murine podocytes (Markus Bitzer
and … Markus Bitzer is recipient of a research fellowship from the National Kidney Foundation of …

[HTML][HTML] Apoptosis in podocytes induced by TGF-β and Smad7

M Schiffer, M Bitzer, ISD Roberts… - The Journal of …, 2001 - Am Soc Clin Investig
Primary and secondary forms of focal segmental glomerulosclerosis (FSGS) are characterized
by depletion of podocytes and constitute a central manifestation of chronic progressive …

Genetic programs of epithelial cell plasticity directed by transforming growth factor-β

J Zavadil, M Bitzer, D Liang, YC Yang… - Proceedings of the …, 2001 - National Acad Sciences
Epithelial–mesenchymal transitions (EMTs) are an essential manifestation of epithelial cell
plasticity during morphogenesis, wound healing, and tumor progression. Transforming …

A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA

M Bitzer, G von Gersdorff, D Liang… - Genes & …, 2000 - genesdev.cshlp.org
A number of pathogenic and proinflammatory stimuli, and the transforming growth factor-β (TGF-β)
exert opposing activities in cellular and immune responses. Here we show that the …

[HTML][HTML] Caveolin-1 regulates transforming growth factor (TGF)-β/SMAD signaling through an interaction with the TGF-β type I receptor

B Razani, XL Zhang, M Bitzer, G Von Gersdorff… - Journal of Biological …, 2001 - ASBMB
Transforming growth factor-β (TGF-β) signaling proceeds from the cell membrane to the
nucleus through the cooperation of the type I and II serine/threonine kinase receptors and their …

Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker

…, JYC Lai, Y Zhou, JJ Hawkins, M Bitzer… - Science translational …, 2015 - science.org
Chronic kidney disease (CKD) affects 8 to 16% people worldwide, with an increasing incidence
and prevalence of end-stage kidney disease (ESKD). The effective management of CKD …

Defining cell-type specificity at the transcriptional level in human disease

…, F Eichinger, V Nair, JB Hodgin, M Bitzer… - Genome …, 2013 - genome.cshlp.org
Cell-lineage–specific transcripts are essential for differentiated tissue function, implicated in
hereditary organ failure, and mediate acquired chronic diseases. However, experimental …

Glomerular aging and focal global glomerulosclerosis: a podometric perspective

JB Hodgin, M Bitzer, L Wickman… - Journal of the …, 2015 - journals.lww.com
Kidney aging is associated with an increasing proportion of globally scarred glomeruli,
decreasing renal function, and exponentially increasing ESRD prevalence. In model systems, …

[HTML][HTML] An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy

…, YF Wu, JB Hodgin, RG Nelson, M Bitzer… - Nature …, 2016 - nature.com
It is important to find better treatments for diabetic nephropathy (DN), a debilitating renal
complication. Targeting early features of DN, including renal extracellular matrix accumulation (…

Inhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS

…, LS Higgins, AF List, M Bitzer… - Blood, The Journal …, 2008 - ashpublications.org
MDS is characterized by ineffective hematopoiesis that leads to peripheral cytopenias.
Development of effective treatments has been impeded by limited insight into pathogenic …